These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 8651041
1. Vinorelbine and cisplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter Czech study. Adam Z, Coupková H, Kolek V, Kucera M, Loffelmann L, Martinez A, Nováková M, Průsa P, Reiterer P, Skalová B. Acta Med Austriaca; 1995; 22(5):120-4. PubMed ID: 8651041 [Abstract] [Full Text] [Related]
2. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer. Souquet PJ, Fournel P, Bohas CH, Fortune IC, Chatte G. Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239 [Abstract] [Full Text] [Related]
3. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE. Cancer J Sci Am; 1995 Apr; 1(4):288-94. PubMed ID: 9166490 [Abstract] [Full Text] [Related]
4. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. Vokes EE, Drinkard LC, Samuels BL, Hoffman PC, Watson S, Bitran JD, Haraf DJ, Ferguson MF, Golomb HM. Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772 [Abstract] [Full Text] [Related]
5. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC. Lena MD, Ramlau R, Hansen O, Lorusso V, Wagner L, Barni S, Cristovao MM, Huber R, Alberola V, Mitrovic M, Colin C, Gasmi J. Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980 [Abstract] [Full Text] [Related]
6. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer. Hirose T, Mizutani Y, Ohmori T, Ishida H, Hosaka T, Ando K, Shirai T, Okuda K, Ohnishi T, Horichi N, Kubota H, Adachi M. Cancer Chemother Pharmacol; 2006 Sep; 58(3):361-7. PubMed ID: 16331494 [Abstract] [Full Text] [Related]
7. Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study. Cigolari S, Curcio C, Maiorino A, Sessa R, Cioffi A, Massimo M. Anticancer Res; 2003 Sep; 23(2C):1803-9. PubMed ID: 12820462 [Abstract] [Full Text] [Related]
8. Combined regional and systemic chemotherapy for advanced and inoperable non-small cell lung cancer. Müller H. Eur J Surg Oncol; 2002 Mar; 28(2):165-71. PubMed ID: 11884052 [Abstract] [Full Text] [Related]
9. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study. Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P. Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041 [Abstract] [Full Text] [Related]
10. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study. Vokes EE, Haraf DJ, Masters GA, Hoffman PC, Drinkard LC, Ferguson M, Olak J, Watson S, Golomb HM. Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237 [Abstract] [Full Text] [Related]
11. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale). Gebbia V, Galetta D, Lorusso V, Caruso M, Verderame F, Pezzella G, Borsellino N, Durini E, Valenza R, Agostara B, Colucci G, Gruppo Oncologico Italia Meridionale. Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419 [Abstract] [Full Text] [Related]
12. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance. Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170 [Abstract] [Full Text] [Related]
14. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer. Yasuda H, Yamaya M, Nakayama K, Sasaki T, Ebihara S, Kanda A, Asada M, Inoue D, Suzuki T, Okazaki T, Takahashi H, Yoshida M, Kaneta T, Ishizawa K, Yamanda S, Tomita N, Yamasaki M, Kikuchi A, Kubo H, Sasaki H. J Clin Oncol; 2006 Feb 01; 24(4):688-94. PubMed ID: 16446342 [Abstract] [Full Text] [Related]
18. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial. Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV. Cancer; 1996 Oct 15; 78(8):1701-7. PubMed ID: 8859183 [Abstract] [Full Text] [Related]
19. Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer. Mori K, Kamiyama Y, Kondo T, Kano Y, Tominaga K. Cancer Chemother Pharmacol; 2004 Feb 15; 53(2):129-32. PubMed ID: 14605861 [Abstract] [Full Text] [Related]
20. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study. Rusu P, Ciuleanu TE, Cernea D, Pelau D, Gaal V, Cebotaru C, Guttman T, Todor N, Ghilezan N. J BUON; 2007 Feb 15; 12(1):33-9. PubMed ID: 17436399 [Abstract] [Full Text] [Related] Page: [Next] [New Search]